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Summary
Asexual blood stages of the malaria parasite, which
cause all the pathology associated with malaria,
can readily be genetically modified by homologous
recombination, enabling the functional study of para-
site genes that are not essential in this part of the life
cycle. However, no widely applicable method for con-
ditional mutagenesis of essential asexual blood-stage
malarial genes is available, hindering their functional
analysis. We report the application of the DiCre
conditional recombinase system to Plasmodium fal-
ciparum, the causative agent of the most dangerous
form of malaria. We show that DiCre can be used to
obtain rapid, highly regulated site-specific recom-
bination in P. falciparum, capable of excising loxP-
flanked sequences from a genomic locus with close
to 100% efficiency within the time-span of a single
erythrocytic growth cycle. DiCre-mediated deletion of
the SERA5 3’ UTR failed to reduce expression of the
gene due to the existence of alternative cryptic polya-
denylation sites within the modified locus. However,
we successfully used the system to recycle the most
widely used drug resistance marker for P. falciparum,
human dihydrofolate reductase, in the process pro-
ducing constitutively DiCre-expressing P. falciparum
clones that have broad utility for the functional analy-
sis of essential asexual blood-stage parasite genes.
Introduction
The malaria parasite shares its life cycle between a verte-
brate host and a mosquito vector, but all the clinical mani-
festations of malaria are caused by replication of the
asexual blood stages within circulating erythrocytes. In the
case of Plasmodium falciparum, responsible for the most
life-threatening form of human malaria, asexual blood-
stage forms can be maintained in continuous culture in
human erythrocytes (Trager and Jensen, 1976), facilitating
study of this important part of the life cycle. Advances in
genetic tools for the modification of malarial genes have
accelerated understanding of the biology of the parasite,
aided within the last decade by the acquisition of the entire
genome sequences of P. falciparum and several other
Plasmodium species (e.g. Gardner et al., 2002; Pain et al.,
2008). Because of the relative accessibility of asexual
blood stages, these are always used for the introduction of
targeting DNAconstructs designed for genetic modification
by ectopic transgene expression or homologous recombi-
nation. Since expression of many Plasmodium genes is
stage-specific this allows disruption of genes with essential
roles restricted to other parts of the life cycle, including the
mosquito and exoerythrocytic life cycle stages. In contrast,
disruption of parasite genes that are indispensable for
blood-stage growth is lethal, preventing the establishment
of null mutants and representing a bottleneck in the func-
tional analysis of these genes. In attempts to overcome
this, there has been great interest in developing conditional
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genetic tools suitable for exogenous control of gene
expression in Plasmodium. One system in which the gene
product of interest is fused to a destabilization domain
that can be stabilized by small ligands, has been used
in P. falciparum with some success (Armstrong and
Goldberg, 2007; Russo et al., 2009; Dvorin et al., 2010;
Muralidharan et al., 2011) but requires that the destabiliza-
tion tag does not interfere with protein function. Moreover,
since the destabilization domain mediates protein degra-
dation by targeting it to the proteasome, the system has
limited utility for proteins that are trafficked via the parasite
secretory pathway. Tet repressor (TetR)-based regulation
of transcription has proven difficult to develop in Plasmo-
dium and there are no reports of efficient repression of
transcription by TetR in these parasites. The most com-
monly used tetracycline-sensitive transactivator, a fusion
between TetR and the Herpes simplex virus VP16 protein,
does not activate minimal promoters in the group of
apicomplexan parasites to which Plasmodium belongs
(Meissner et al., 2001). An artificial transactivation domain
(TATi), when fused to TetR has been successfully used in
the related apicomplexan Toxoplasma gondii to generate
conditional mutants (Meissner et al., 2002), and has been
used with some success for inducible transgene expres-
sion in P. falciparum (e.g. Meissner et al., 2005; Gilson
et al., 2008; O’Neill et al., 2011). Very recently, functional
transactivation domains based on apicomplexan ApiAP2
transcription factors have been elegantly used to obtain
stage-dependent tetracycline-dependent gene knock-
down in T. gondii and Plasmodium (Pino et al., 2012).
Though of great potential, these conditional approaches all
require transactivator-responsive minimal promoters that
accurately mimic the transcriptional profile of the gene of
interest. Despite a promising report describing the use of
peptide-morpholino oligomer conjugates in Plasmodium
(Augagneur et al., 2012), most other widely used gene
silencing approaches that affect transcript stability, trans-
lation or splicing, such as morpholino oligonucleotides,
self-cleaving ribozymes and RNA interference (RNAi),
have yet to be proven widely effective in Plasmodium
(Agop-Nersesian et al., 2008), in the case of RNAi
because of the absence of crucial components of the
pathway in the parasite (Baum et al., 2009).
Site-specific recombination using phage or yeast-
derived recombinases is a method of choice in many
models for gene modification or deletion. Two recombi-
nases, Cre and flippase (FLP), have been most widely
used. Both recognize short, 34 bp sequences, respec-
tively called loxP and FRT, and mediate either excision or
inversion of intervening sequences depending on the rela-
tive orientation of the recognition motifs. FLP has been
successfully used in the Plasmodium berghei rodent
malaria model, exploiting an approach in which develop-
mental stage-specific recombinase activity was obtained
by placing FLP under the control of parasite promoters
active only in insect stages (Combe et al., 2009; Falae
et al., 2010; Giovannini et al., 2011; Lacroix et al., 2011).
This system has only limited applicability for studying
essential asexual blood stage-specific genes. Cre is
active in both P. falciparum (O’Neill et al., 2011) and
T. gondii (Brecht et al., 1999), but attempts to obtain
robust regulation of this activity have been unsuccessful,
resulting only in constitutive recombinase activity unsuit-
able for conditional gene modifications. Forms of Cre that
can be regulated by hormones or small molecules have
been described. In the DiCre system, Cre is expressed in
the form of two separate, enzymatically inactive polypep-
tides, each fused to a different rapamycin-binding protein
(either FKBP12 or FRB, the rapamycin-binding domain
of the FKBP12-rapamycin-associated protein mTOR)
(Chen et al., 1995; Choi et al., 1996; Liang et al., 1999).
Rapamycin-induced heterodimerization of the two compo-
nents restores recombinase activity (Jullien et al., 2003;
2007). Recent work has shown that this technology func-
tions efficiently in T. gondii, with recombination rates of up
to 96% upon induction with rapamycin (Andenmatten
et al., 2013).
Here we show that DiCre provides rapid, highly regu-
lated Cre recombinase activity in P. falciparum, capable of
excising loxP-flanked (floxed) sequences from a genomic
locus with close to 100% efficiency within the time-span of
a single erythrocytic growth cycle. As proof of principle,
we have used the system to recycle one of the most
widely used drug selectable markers, in the process pro-
ducing DiCre-expressing P. falciparum clones that will be
of great utility for conditional modification of P. falciparum
genes, including those essential for asexual blood-stage
growth.
Results
Design of a ‘single vector’ strategy for DiCre-mediated
gene knock-down and selectable marker recycling in
P. falciparum
X-ray crystal structure analysis of Cre recombinase has
shown that it comprises two major helical domains linked
by a short, relatively flexible segment (Guo et al., 1997). In
earlier work, Jullien et al. (2007, 2003) showed that the
rapamycin-mediated dimerization of two distinct, enzy-
matically inactive polypeptides approximately correspond-
ing to the individual domains of Cre (residues Thr19–
Asn59, called Cre59, and Asn60-343, called Cre60) each
fused to a different rapamycin-binding protein (FKBP12
and FRB respectively), resulted in the reconstitution of Cre
recombinase activity. Because induction of recombinase
activity upon addition of rapamycin does not require de
novo biosynthesis of the recombinase, induction is very
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rapid. The N-terminal FKBP12 and FRB fusion partners are
linked to their partner Cre sequences through short Gly/
Ser-rich linkers, and each protein possesses a nuclear
localization signal at its extreme N-terminus. To adapt the
DiCre system to P. falciparum, we first designed a DiCre
cassette in which expression of the FKBP-Cre59 and
FRB-Cre60 genes were placed under the control of the
strong, constitutive P. falciparum BiP and hsp86 promot-
ers, arranged in a head-to-head orientation (Fig. 1A). For
introduction of the expression cassette into the parasite,
we decided to incorporate this cassette into a larger target-
ing vector designed to integrate by homologous recombi-
nation into a P. falciparum locus in such a way that
induction of recombinase activity would produce two dis-
tinct effects. First, we wanted to remove the drug selecta-
ble marker used to select for the initial integration event.
This is because very few drug resistance markers are
currently available for experimental genetic modifications
in Plasmodium (Lin et al., 2011), and so the recycling of
selectable markers increases flexibility for consecutive
gene modifications. Second, we wished to explore the
possibility of using a ‘single vector’ strategy to obtain
downregulation or knockout of a selected gene of interest
(GOI). The 3’ UTR of eukaryotic genes generally regulates
correct transcription termination and polyadenylation of
the mRNA, important for mRNA stability and trafficking.
Several previous reports (e.g. Yeoh et al., 2007; Combe
et al., 2009; Giovannini et al., 2011) have shown that,
whereas the endogenous 3’ UTR of Plasmodium genes
can usually be replaced with other Plasmodium 3’ UTR
sequences without deleterious effects on gene expression,
complete removal of the 3’ UTR can severely ablate
expression levels, effectively resulting in gene knock-
down. To investigate the use of DiCre as a means of
obtaining conditional gene knock-down in a manner ame-
nable to medium-throughput gene analysis, we sought to
use it to obtain conditional removal of the 3’ UTR of a GOI.
As an initial target GOI we chose SERA5 (PlasmoDB ID
PF3D7_0207600), a member of a family of nine SERA
genes in P. falciparum (Arisue et al., 2011). Previous work
(Miller et al., 2002; McCoubrie et al., 2007) has shown that
whereas most members of this gene family can be indi-
vidually disrupted with no phenotypic consequences, the
SERA5 and SERA6 genes are refractory to disruption
using conventional targeted homologous recombination,
suggesting that they are indispensable in asexual blood
stages of the parasite life cycle. SERA5 is expressed as an
abundant, soluble parasitophorous vacuole protein of
~ 126 kDa, and is thought to play a role in schizont rupture
(egress) and/or erythrocyte invasion by released mero-
zoites (reviewed in Blackman, 2008). However its precise
function is unknown.
In initial preliminary work we produced construct
pHH1SERA5chimWT, designed to integrate by single-
crossover homologous recombination into the SERA5
locus to produce a chimeric gene still under the control of
its endogenous promoter and encoding the unmodified
SERA5 primary amino acid sequence, but using the 3’
UTR from the P. berghei dihydrofolate reductase (dhfr)
gene (Pbdt 3’ UTR). The use of recodonized sequence
within the construct was not essential for this work,
but provided the option in future work of introducing
desired mutations into this region in the knowledge that
single-crossover recombination would preferably occur
upstream of the recodonized sequence, as described pre-
viously (Child et al., 2010; Ruecker et al., 2012). Trans-
fection of P. falciparum with pHH1SERA5chimWT and
selection in the presence of the antifolate drug WR22910
resulted in rapid outgrowth of parasites in which integra-
tion of the construct had taken place in the expected
manner. Parasite clones obtained by limiting dilution from
these lines were phenotypically indistinguishable from
wild-type parasites and expressed wild-type levels of
SERA5 protein (R. Stallmach and M. Blackman, in prepa-
ration), showing that the chimeric SERA5 gene and
appended Pbdt 3’ UTR were fully functional in maintaining
full SERA5 expression levels.
Rapid and efficient site-specific recombination at a
genomic P. falciparum locus mediated by induction of
DiCre activity
Encouraged by the above result, we produced con-
structs pHH1_DCmock and pHH1_SERA5del3DC
(Fig. 1A), which used the same targeting sequence as
pHH1SERA5chimWT for homologous integration into the
SERA5 locus, but were designed to allow subsequent
deletion of the Pbdt 3’ UTR sequence downstream of the
modified SERA5 gene, along with the human dhfr (hdhfr)
selectable marker, upon induction of DiCre activity. While
pHH1_SERA5del3DC contained the complete DiCre
cassette shown in Fig. 1A, pHH1_DCmock contained a
‘mock’ cassette in which the hsp86 and BiP promoters
were replaced by a single ~ 930 bp stretch of bacterial
coding sequence not expected to drive expression of
the DiCre proteins, thereby acting as a negative control
for DiCre expression. Transfection of both constructs into
P. falciparum, followed by limiting dilution cloning of
the resulting WR99210-resistant lines, resulted in the
isolation of several parasite clones in which integration
of pHH1_DCmock or pHH1_SERA5del3DC had taken
place (Fig. 1B). To examine the effects of induction of
DiCre activity, highly synchronous young ring-stage para-
sites of clones 2E9 and 3E9 (containing integrated
pHH1_SERA5del3DC) and clone 1B7 (containing the inte-
grated ‘mock’ construct pHH1_DCmock) were obtained by
adding purified mature schizonts to fresh erythrocytes,
allowing invasion to take place for a period of just 2 h, then
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removing residual schizonts using a combination of Percoll
centrifugation and sorbitol-mediated lysis of the schizonts.
The resulting cultures, now maintained in the absence of
WR99210, were each divided into two and treated for
exactly 4 h with either rapamycin (100 nM) or vehicle only
(DMSO, 1% v/v). The parasites were then washed,
returned to culture in medium lacking WR99210, and
sampled at 24 h post invasion (mid-trophozoite stage) and
45 h post invasion (mature schizont stage). Genomic para-
site DNA prepared from each time point was then analysed
by PCR, using primers diagnostic for either the intact
modified locus (primers a and b indicated in Fig. 1A), or the
expected genomic product of DiCre-mediated site-specific
recombination (primers c and b; Fig. 1A). As shown in
Fig. 2A, rapamycin treatment resulted in the efficient con-
version of the intact modified SERA5 locus to the expected
excised form of the locus in which deletion of the floxed
sequence had taken place (shown in Fig. 1A). Excision
was clearly evident by 24 h post invasion, and by 45 h post
invasion appeared almost complete, with very little of the
intact locus detectable. No excision was detectable by
PCR in the 1B7 clone irrespective of whether the parasites
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had been exposed to rapamycin treatment, indicating a
requirement for DiCre expression in the parasite. Of par-
ticular importance, no background excision was detectable
in 2E9 or 3E9 parasites that had not been exposed to
rapamycin, demonstrating robust regulation of DiCre-
mediated recombinase activity. To obtain a quantitative
measure of excision efficiency, genomic DNA prepared
from the 45 h time point was examined by Southern blot
(Fig. 2B). This confirmed the high efficiency of the induced
site-specific recombination event and allowed it to be
calculated by phosphorimager analysis as ~ 98% by com-
parison of the intensity of the signals corresponding to the
excised and non-excised species in digests of genomic
DNA from the rapamycin-treated parasites.
DiCre-mediated excision of the SERA5 3’ UTR fails to
silence gene expression due to transcription termination
at an alternative cryptic polyadenylation site
The anticipated result of excision of the floxed sequence
downstream of the modified SERA5 locus was to both
remove the Pbdt 3’ UTR, expected to reduce SERA5
expression levels, and also to excise the hdhfr cassette
which provides resistance to WR99210 (Fig. 1A). To
evaluate the first of these possible phenotypic outcomes,
45-h-old clone 2E9 and 3E9 schizonts from the experi-
ment described above were examined by IFA using a mAb
(24C6.1F1) specific for SERA5. Unexpectedly, no dis-
cernible difference in fluorescence intensity was evident
between parasites that had been exposed to rapamycin at
ring stage, and the parallel cultures that had not been
rapamycin-treated (Fig. 3A). Given the efficiency of exci-
sion demonstrated by PCR and the Southern blot analysis
(Fig. 2), this suggested that removal of the Pbdt 3’ UTR
from the modified SERA5 locus was not sufficient to sig-
nificantly reduce SERA5 protein expression levels. This
was confirmed by Western blot analysis (Fig. 3B).
Although efficient knock-down of Plasmodium gene
expression has previously been achieved through
removal of 3’ UTR regulatory sequences (e.g. Giovannini
et al., 2011), the approach is not uniformly successful. In
a recent in-depth investigation of such a case, Ecker et al.
(2012) showed that FRT-mediated excision of the 3’ UTR
of the P. berghei chloroquine resistance transporter gene
(pbcrt) failed to ablate gene expression due to the pres-
ence of alternative polyadenylation sites at the 3’ end of
the excised locus, that were efficiently used to stabilize
the pbcrt mRNA. To address whether a similar phenom-
enon might explain the continued robust SERA5 expres-
sion observed following DiCre-mediated removal of the
Pbdt 3’ UTR in the present study, the rapamycin-treated
clone 3E9 parasites were cloned by limiting dilution (in the
absence of WR99210) to obtain genetically homogene-
ous subclones harbouring the excised genomic locus
(Fig. 3C). A total of three subclones were expanded and
examined by analytical PCR for the presence of the
excised genomic architecture, as well as for the presence
of the wild-type SERA5 coding sequence, which could
potentially be reconstituted in these transgenic parasites
through spontaneous reversion by homologous recombi-
Fig. 1. Design of the DiCre targeting vector, predicted homologous integration and recombinase-mediated excision events, and isolation of
transgenic P. falciparum clones.
A. The boxed insert shows an expanded view of the PfDiCre expression cassette. Expression of the DiCre components (black block arrows) is
driven by the P. falciparum BiP and hsp86 promoters, with transcription termination and polyadenylation being regulated by the 3’ UTR
sequences from the P. falciparum calmodulin (CAM) and hsp86 genes. Main figure: schematic (not to scale) showing the main features of the
pHH1_SERA5del3DC plasmid construct. Targeting sequence derived from the native SERA5 gene was fused in-frame to recodonized
sequence (hatched) derived from the SERA5synth gene. A single EcoNI restriction site (E) within the hdhfr cassette (black box), which confers
resistance to the antifolate WR99210, is shown. The PfDiCre cassette contains another EcoNI site as well as a unique HindIII site (H). The
P. berghei dhfr 3’ UTR (Pbdt 3’ UTR) lies just downstream of the SERA5synth sequence in the plasmid. Two loxP sites are indicated as black
arrowheads in the plasmid. The endogenous SERA5 locus, which contains three introns, is shown below, as is the expected result of
homologous integration of the entire plasmid and the architecture of the modified locus relative to flanking HindIII and EcoNI sites. Episomal
plasmids are harboured as concatamers in P. falciparum, so integration of more than one copy can occur. However, because the plasmid
contains only a partial SERA5 sequence not preceded by a promoter, the only SERA5 copy to be transcribed is the modified chimeric gene
directly downstream of the endogenous promoter. DiCre-mediated recombination should result in excision of both the Pbdt 3’ UTR from the
modified SERA5 locus, and the hdhfr selectable marker, as well as removal of the entire pHH1_SERA5del3DC plasmid backbone. Note that,
even if concatamers of pHH1_SERA5del3DC were to integrate, DiCre-mediated excision would still result in removal of all sequence between
the duplicated loxP sites, leading to the terminal excised structure shown, in which only a single copy of the modified SERA5 coding sequence
remains under the control of its endogenous promoter, and just a single genomic loxP site remains. Positions of primers +27, -11 and -25
used for diagnostic PCR of the expected integration of pHH1_SERA5del3DC and pHH1_DCmock (which is identical aside from the presence
of a mock promoter in the place of the hsp86 and BiP promoters within the PfDiCre cassette) are shown by white arrowheads joined by dotted
lines. Predicted sizes of the amplicons obtained with primer pairs +27 plus -11, and +27 plus -25, are 1911 bp and 1737 bp respectively.
Primer +27 lies just upstream of the targeting sequence in the plasmid, so cannot produce a product from the transfection construct. Positions
of primers CAM5‘_R4 (a), hsp86 3’_R1 (b) and sgs5seq5F (c) used for diagnostic PCR analysis of the modified and excised locus are
indicated by black arrowheads joined by dotted lines. Predicted sizes of amplicons obtained with primers a plus b, and c plus b are 428 bp
and 804 bp respectively. The relative position of the probe used for Southern analysis is indicated.
B. Diagnostic PCR analysis of genomic DNA from clones derived by limiting dilution of parasites transfected with constructs
pHH1_SERA5del3DC or pHH1_DCmock, confirming integration into the SERA5 locus as expected. Only wild-type (wt) parasite DNA produced
a product with primers +27 plus -25, while the amplicon produced with primer pair +27 plus -11, diagnostic of the expected integration event,
was obtained only from the transgenic clones.
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nation between the excised modified locus (which lacks
the hdhfr selectable marker) and the downstream partially
duplicated SERA5 ORF (i.e. the reverse of the single-
crossover recombination event depicted in Fig. 1). As
expected, all three subclones exhibited the same excised
genomic architecture as that in the rapamycin-treated
clone 3E9 parasites, with no signs of the intact modified
locus and no reversion to the wild-type locus, even after
continuous culture for > 2 months (data not shown). One
of the subclones (called 1G5DiCre) was then analysed by
rapid amplification of cDNA ends (3’ RACE), in parallel
with the non-rapamycin-treated parental 3E9 clone, using
nested forward primers specific for the SERA5synth gene to
examine the 3’ structure of the chimeric SERA5 mRNA
transcript(s). As shown in Fig. 3D, there was a clear dif-
ference in the size on agarose gel electrophoresis of the
dominant 3’ RACE products from these two parasite
clones, consistent with transcription termination occurring
at distinct sites, as expected. To examine this in detail, the
3’ RACE products were cloned and sequenced. A com-
parison of these sequences (Supporting Information Fig.
S1) showed that mRNA transcribed from the non-excised
chimeric SERA5 locus underwent polyadenylation as
expected at a single major position ~ 247 bp into the Pbdt
3’ UTR. In contrast, in the excised locus polyadenylation
occurred instead at a position within the inverted hsp86 3’
UTR which lies immediately downstream of the SERA5
stop codon in the excised locus (Fig. 3E). No obvious
sequence similarity was evident around the polyadenyla-
tion sites (Fig. 3E and Fig. S1). Note that the length of the
sequenced RACE products was approximately in line with
the observed size of the dominant signals observed on gel
electrophoresis (~ 460 bp and ~ 490 bp for clone 3E9 and
subclone 1G5DiCre respectively), suggesting that the
Fig. 2. Rapid, regulated and highly efficient DiCre-mediated excision of a floxed genomic P. falciparum sequence.
A. PCR analysis showing detection of excision following a 4-h-long treatment of clones 2E9, 3E9 or 1B7 with rapamycin at ring stage.
Genomic DNA was prepared from the treated parasites at 24 h and 45 h post invasion. Primer pairs a plus b detect the modified locus prior to
excision, while primers c plus b detect the appearance of the rearranged locus resulting from site-directed recombination between the loxP
sites (see Fig. 1A). Primers specific for the msp1 gene (MSP1_FOR and MSP1_REV; see Table S1) were used as a control to confirm the
presence of genomic DNA in all the template samples.
B. Southern blots confirming efficient rapamycin-induced excision in the 2E9 and 3E9 transgenic P. falciparum clones. The genomic DNA used
for the Southern blot was prepared at 45 h post invasion. Phosphorimager quantification of the 6.5 kb ‘excised locus’ signals in the
rapamycin-treated 2E9 and 3E9 samples, compared with the position in the same tracks corresponding to the non-excised 9.0 kb species
(where no band is visible by eye) showed that excision was 97.9% efficient in the case of clone 2E9, and 97.2% efficient in the case of clone
3E9. However, even upon prolonged exposure, no residual ‘non-excised’ signal was visually detectable in the genomic DNA digests from the
rapamycin-treated parasites (not shown).
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Fig. 3. DiCre-mediated excision of the Pbdt 3’ UTR does not reduce SERA5 expression levels due to the presence of an alternative
polyadenylation site within the inverted hsp86 3’ UTR.
A. IFA analysis of clone 3E9 schizonts derived from ring-stage parasites treated for 4 h with vehicle only (DMSO) or 100 nM rapamycin to
induce DiCre-mediated excision of the Pbdt 3’ UTR from the modified SERA5 locus (see Figs 1A and 2). Parasites were probed with mAbs
specific for SERA5, or MSP1 as a control. No change in SERA5 expression levels was detected following rapamycin treatment.
4,6-Diamidino-2-phenylindol (DAPI) was used to detect parasite nuclei.
B. Western blot analysis of extracts of the same schizont populations. Different volumes of an SDS extract of intact schizonts were probed
with the anti-SERA5 mAb 24C6.1F1. The results confirm no significant difference in SERA5 expression levels between the control and
rapamycin-treated parasites.
C. Workflow showing isolation by limiting dilution of parasite subclones from rapamycin-treated P. falciparum clone 3E9, performed in order to
obtain genetically homogeneous parasites harbouring the excised locus architecture. Subclone 1G5DiCre was used for subsequent 3’ RACE
and transfection analysis.
D. Agarose gel electrophoresis of 3’ RACE products amplified from total RNA of clone 3E9 and subclone 1G5DiCre. A dominant RACE
product was obtained in each case. No product was obtained in the absence of reverse transcriptase (not shown). Sizes in kb of DNA marker
fragments (left-hand lane) are indicated.
E. Schematic (not to scale) showing the overall structure of the modified SERA5 locus in clones 3E9 (prior to excision) and subclone
1G5DiCre (following excision), depicted as in Fig. 1A. Relative positions of polyadenylation sites identified by sequencing of the cloned 3’
RACE products are indicated in red (see Fig. S1 for the aligned sequence data). Positions of SERA5synth gene-specific forward primers used
for the semi-nested 3’ RACE are shown (red arrowheads).
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sequenced clones were representative of the major
RACE products in each case. These observations
strongly suggest that the hsp86 3’ UTR sequence (which
was present in the modified locus in order to regulate
transcription of the FRB-Cre60 component of the DiCre
cassette; see Fig. 1 insert), possesses bidirectional tran-
scription termination and polyadenylation functionality.
Collectively, our results explain the observed lack of
SERA5 knock-down upon removal of the Pbdt 3’ UTR.
Efficient recycling of the hdhfr selectable marker
through DiCre-mediated excision, and production of
DiCre-expressing ‘recipient’ P. falciparum clones
To address the second predicted outcome of DiCre-
mediated excision from the modified SERA5 locus –
removal of the hdhfr selectable marker cassette – sch-
izonts from all three clones 2E9, 3E9 and 1B7 treated with
or without rapamycin as described in Fig. 2 were allowed to
undergo invasion overnight in the absence of WR99210,
to form a new generation of ring-stage parasites. Each
culture was then divided into two, and culture continued in
either the presence or absence of WR99210. As shown in
Fig. 4A and B, whereas rapid expansion of the non-
rapamycin-treated 2E9 and 3E9 clones took place in both
the presence and absence of WR99210, those 2E9 and
3E9 parasites that had been rapamycin-treated at ring
stage in the first cycle instead displayed extensive cell
death in the presence of WR99210, consistent with the
removal of the hdhfr cassette in the great majority of the
population. In contrast, and again consistent with the exci-
sion results, the 1B7 clone parasites continued to grow
well, irrespective of whether they had been rapamycin
treated, or of the presence of WR99210. These data con-
vincingly support the PCR and Southern blot results,
showing efficient removal of the hdhfr resistance marker in
the 2E9 and 3E9 parasites upon rapamycin-induced,
DiCre-mediated excision of the floxed genomic sequence.
Prolonged culture (> 28 days) of the rapamycin-treated
2E9 and 3E9 parasites in the presence of WR99210
resulted in the eventual outgrowth of drug-resistant para-
sites (not shown). We reasoned that these surviving
parasites (referred to as 2E9WR and 3E9WR) likely rep-
resented a very small minority of the original parasite
clones that had either not undergone DiCre-mediated
excision upon the first round of rapamycin treatment, or
had undergone anomalous excision. To test this predic-
tion, the expanded 2E9WR and 3E9WR parasite lines
were synchronized then subjected to a second 4 h
treatment  rapamycin, and their genomic structure ana-
lysed again by PCR 40 h later. For comparison these
experiments were performed in parallel with similar treat-
ments of the original 2E9 and 3E9 clones that had not
previously been exposed to rapamycin. As shown in Fig.
S2, whereas the original 2E9 and 3E9 clones exhibited
efficient rapamycin-dependent excision as seen previ-
ously, the WR99210-resistant parasite lines showed
either poor excision (3E9WR) or good excision but with
signs of pre-existing excision (2E9WR) which presumably
had failed to remove the hdhfr cassette, leaving these
parasites WR99210-resistant. While these results cannot
be fully explained without detailed genomic sequencing of
the modified loci, they were consistent with the recovered
WR99210-resistant parasites being the results of very
Fig. 4. DiCre-mediated excision successfully recycles the hdhfr selectable marker and produces a P. falciparum recipient clone that
constitutively expresses DiCre.
A. Typical growth assay showing the results of expanding the control (DMSO-treated) or rapamycin-treated clones 2E9, 3E9 and 1B7 in the
presence or absence of WR99210. As predicted based on the efficient excision of the hdhfr cassette, the rapamycin-treated 2E9 and 3E9
clones did not replicate in medium containing WR99210. In contrast, rapamycin treatment of clone 1B7, which harbours the ‘mock’ DiCre
cassette, had no effect on growth under any conditions. Day 0 corresponds to the point (~ 60 h following treatment with rapamycin or DMSO)
at which the cultures were transferred to fresh medium  WR99210. Each data point represents the mean of triplicate microscopic counts,
each of at least 500 cells. Error bars,  1 SD.
B. Giemsa-stained microscopic images of clone 2E9 at day 3 following the start of culture in the presence of WR99210. The appearance of
the poorly staining, dysmorphic schizonts (arrowed) in the rapamycin-treated cultures is typical of that usually observed after WR99210
treatment of drug-susceptible wild-type parasites. By day 4, these had completely degenerated and disappeared from the cultures. In contrast,
the DMSO-treated control cultures contain numerous healthy schizonts and young ring stages, indicative of normal levels of growth.
C. Induction of DiCre-mediated excision in the 1G5DiCre recipient subclone. Shown (left-hand side) is a schematic of reporter plasmid
construct pHH1_MSP1del3preDiCre (not to scale) alongside results of PCR analysis of DNA isolated from 1G5DiCre parasites harbouring the
plasmid, following treatment  rapamycin. Rapamycin treatment induced efficient excision of the floxed Pbdt 3’ UTR and hdhfr cassette from
the plasmid, proving expression of DiCre from the genomic cassette incorporated into the modified SERA5 locus of the 1G5DiCre parasites.
No excision was observed in the absence of rapamycin. The relative positions of primers used for the PCR are indicated as coloured
arrowheads. Primers used were: 3D7synMSP1_FOR2 (open red); PbDT3’5’R1 (solid red); 3D7endoMSP1_REV4 (blue); 3D7endoMSP1FOR1
(open green); and 3D7synMSP1_REV3 (solid green). See Table S1 for primer sequences. The hatched region in the
pHH1_MSP1del3preDiCre schematic indicates the synthetic (recodonized) msp1 sequence, and the expected sizes of the various amplicons
are indicated. The extreme left-hand and right-hand tracks on the gel contain DNA size markers. The ~ 700 bp fragment (asterisked) present
in the 3D7synMSP1_FOR2 (open red) plus PbDT3’5’R1 (solid red) PCR tracks is a product of mis-priming, since this was also amplified from
1G5DiCre parasites that had not been transfected with plasmid pHH1_MSP1del3preDiCre (not shown). Rapamycin treatment results in loss of
the 820 bp PCR product and the appearance of an excision-specific 1149 bp product. Note that under the PCR conditions used, no product
was expected to be amplified from the intact pHH1_MSP1del3preDiCre with primers 3D7synMSP1_FOR2 (open red) and
3D7endoMSP1_REV4 (blue) due to the large size of that predicted product.
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low-level anomalous DNA rearrangements that were not
typical of the great majority of the rapamycin-treated 2E9
and 3E9 parasites.
To finally demonstrate the utility of our approach for
producing a DiCre-expressing recipient parasite line with
potential for further gene manipulation, we returned to a
more detailed analysis of subclone 1G5DiCre, which was
derived as described above by limiting dilution cloning
(in the absence of WR99210) from clone 3E9 parasites
that had been rapamycin-treated to induce excision of the
hdhfr cassette. To test for expression of DiCre from the
integrated genomic DiCre cassette in these parasites,
subclone 1G5DiCre was transfected by electroporation
with a reporter construct called pHH1_MSP1del3preDiCre
(Fig. 4C). This construct contains a hdhfr selectable
marker cassette and a chimeric msp1 gene fragment,
followed by the Pbdt 3’ UTR and flanked by loxP sites;
importantly, it lacks a DiCre cassette, so excision of the
floxed sequence can only take place if the 1G5DiCre
parasites continue to express DiCre from the integrated
genomic DiCre cassette. 1G5DiCre parasites not sub-
jected to electroporation, or mock-transfected (i.e. sub-
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jected to electroporation in the absence of the transfection
construct), rapidly died upon culture in the presence of
WR99210, as expected (data not shown). In contrast,
drug-resistant parasites appeared in the pHH1_
MSP1del3preDiCre-transfected 1G5DiCre cultures within
6 days. These parasites were expanded, synchronized,
then treated  rapamycin for 4 h as described above and
analysed 40 h later by PCR, using primers designed to
detect excision of the floxed sequence, as well as control
primers. As shown in Fig. 4C, rapamycin treatment
resulted in efficient excision of the floxed sequence
from the episomal pHH1_MSP1del3preDiCre construct,
proving robust constitutive expression of DiCre in the
1G5DiCre parasites. These results confirm the usefulness
of the 1G5DiCre parasite subclone as a recipient line for
future DiCre-mediated mutational analysis of P. falciparum
genes.
Discussion
Despite the medical importance of P. falciparum, and in
particular of its asexual blood-stage life cycle, obtaining
conditional regulation of gene expression in this organism
has proven extremely challenging. The short erythrocytic
life cycle of P. falciparum (~ 48 h) raises particular prob-
lems in this regard; in order to observe developmental
stage-specific phenotypic changes at the population level
in a conditional mutant over the course of a single eryth-
rocytic cycle – especially important if the outcome of
mutagenesis is lethal – switch-off of gene expression
needs to be both efficient and rapid. We have shown here
that the DiCre system meets both those critical require-
ments, allowing rapid, highly regulated and remarkably
efficient site-specific recombination within the course of a
single erythrocytic growth cycle. We designed our strat-
egy to simultaneously impose two measurable effects
on gene expression in our transgenic clones. First we
attempted knock-down of SERA5 expression by removal
of its introduced Pbdt 3’ UTR, anticipating that this would
result in lowered protein expression levels by reducing
mRNA stability. We were surprised to observe no detect-
able change in SERA5 expression levels. SERA5 is
expressed at extraordinarily high levels in asexual blood-
stage schizonts, and indeed is probably one of the most
abundant schizont-stage parasite proteins (Lasonder
et al., 2002; Le Roch et al., 2004). Small alterations in
SERA5 mRNA stability may therefore have little effect on
overall protein levels. We reasoned that an alternative
explanation for the lack of alteration in SERA5 levels
might be the presence of a cryptic 3’ UTR in the apposed
hsp86 3’ UTR, which was shifted adjacent to the SERA5
stop codon following DiCre-mediated excision from the
modified locus (Fig. 1A), even though this was in the
opposite orientation to that previously known to mediate
correct transcription termination. Examination of subclone
1G5DiCre, derived from the rapamycin-treated 3E9 para-
sites, confirmed this suspicion; 3’ RACE analysis identi-
fied a polyadenylation site in the inverted hsp86 3’ UTR at
a position that shows no obvious sequence similarity
to that identified in the authentic Pbdt 3’ UTR, which is
widely used to regulate transcription of transgenes in
both P. falciparum and P. berghei. This suggests that the
hsp86 3’ UTR contains bidirectional transcription termi-
nation and polyadenylation signals. Interestingly, a recent
report from Ecker et al. (2012) made a very similar obser-
vation; following unsuccessful attempts to obtain knock-
down of the pbcrt gene in P. berghei those authors
identified efficient polyadenylation sites in the inverted
3’ UTR from the P. berghei thrombospondin related
adhesive protein (trap) gene, which was translocated to a
position immediately downstream of the pbcrt gene upon
FLP-mediated excision. Together, these findings show
that great caution should be exercised in the design
of constructs intended for removal of 3’ regulatory
sequences as a route to gene knock-down in Plasmo-
dium. Certainly, in the light of our results future work will
focus on alternative approaches to DiCre-mediated
SERA5 knockout, including truncation of the coding
sequence by inserting the upstream loxP site into one of
the 5’-proximal introns within the SERA5 gene, or indeed
floxing the entire locus. This would likely require the
use of a double-crossover strategy to incorporate the
two loxP sites, a feasible approach in P. falciparum
(Duraisingh et al., 2002).
The second intended outcome of DiCre-mediated exci-
sion of the modified SERA5 locus, removal of the hdhfr
selectable marker cassette, resulted as expected in a
dramatic reversal of resistance of the 2E9 and 3E9 clones
to WR99210, consistent with the high efficiency of site-
specific recombination determined by PCR and Southern
blot analysis. Importantly, background excision was unde-
tectable by PCR in the absence of rapamycin treatment,
demonstrating stringent regulation of DiCre activity. The
result demonstrates robust, conditional deletion of what is
effectively an essential parasite transgene in the presence
of the antifolate drug. It also demonstrates the ease with
which the DiCre system can be used to recycle selectable
markers, only a limited number of which are available for
use in Plasmodium. This is crucial for enabling consecutive
genetic manipulations, required for disruption of multiple
genes at different loci, or complementation of knockouts.
Three parasite subclones derived from the rapamycin-
treated 3E9 clone were found to be genetically stable, and
detailed examination of subclone 1G5DiCre showed it to
be readily transformed back to WR99210-resistance by
transfection with a reporter plasmid containing the hdhfr
cassette, confirming recycling of the selectable marker. In
addition we confirmed constitutive expression of DiCre in
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the parasites by demonstrating rapid excision of a floxed
sequence from the input plasmid upon rapamycin treat-
ment of the transfected parasites. The DiCre-expressing
‘recipient’ P. falciparum clones will be invaluable tools for
further gene targeting studies, enabling the use of much
smaller targeting constructs than that described here,
since the constructs will no longer need to incorporate the
~ 5.5 kb DiCre cassette (which is now integrated into the
genome of the recipient parasite clones).
The DiCre strategy presented here will have important
applications in other Plasmodium species, including the
human pathogen Plasmodium knowlesi, which has
recently been adapted to continuous culture in human
erythrocytes (Moon et al., 2013). It also has great potential
for use in rodent malaria models such as the widely used
and highly genetically tractable species P. berghei. DiCre
has previously been shown to be inducible in vivo using
rapamycin (Jullien et al., 2007), and rapamycin is used
clinically as an immunosuppressive agent, even accumu-
lating strongly in erythrocytes following administration
(Yatscoff et al., 1995; Trepanier et al., 1998). We would
therefore expect that it should be possible to induce DiCre
activity in circulating blood-stage rodent parasites by
parenteral administration of rapamycin. As an alternative
approach, and to avoid potential experimental complica-
tions introduced by the immunosuppressive and antiprolif-
erative activities of rapamycin in mice, isolated parasites
(which can be maintained transiently ex vivo) could be
treated briefly in vitro with a ‘pulse’ of rapamycin to induce
DiCre activity, then simply washed and reintroduced into
the animal. Rapamycin does have antimalarial properties,
possibly through binding the parasite FKBP homologue
(Monaghan and Bell, 2005); however, the reported IC50
value of rapamycin against P. falciparum (2.6 mM; Bell
et al., 1994) is much higher than the concentration used
here to induce DiCre activation (100 nM), and in accord
with that we observed no deleterious effects on parasite
growth following brief treatment with the drug. The avail-
ability of a series of rapamycin analogues (‘rapalogues’)
some of which bind certain FRB or FKBP12 mutants well,
but have lowered affinity for endogenous mammalian
FKBP12 or FRAP (Clackson et al., 1998; Pollock and
Clackson, 2002; Bayle et al., 2006), provides even more
potential flexibility for use of DiCre in vitro. Unfortunately
several of these compounds are not suitable for use in mice
as they appear to be rapidly cleared in vivo (Jullien et al.,
2007). This limitation may be overcome by a second-
generation ‘DiCre2’ system currently under development in
which both DiCre components are fused to an FKBP
mutant which can be dimerized by the rapalogueAP20187;
preliminary studies have indicated that this is effective
in vivo with no physiological side-effects (Herman and
Jullien, 2012; also J.-P. Herman and C. Monetti, unpub-
lished). We expect the DiCre strategy to have a marked
impact on understanding of gene function in the malaria
parasite and other apicomplexan pathogens.
Experimental procedures
Reagents and antibodies
Rapamycin was obtained from Sigma, UK (catalogue number
R0395). Stock solutions (10 mM) were prepared in DMSO
and stored in aliquots at -20°C. The antifolate drug WR99210
was from Jacobus Pharmaceuticals (New Jersey, USA).
Monoclonal antibody (mAb) X509, which recognizes the
parasite major merozoite surface protein MSP1, has been
described previously (Blackman et al., 1991), as has the anti-
SERA5 mAb 24C6.1F1 (Delplace et al., 1985), which was a
kind gift of Jean-Francois Dubremetz (University of Montpel-
lier 2, France).
Parasite cultures and transfections
Asexual blood-stage cultures of P. falciparum clone 3D7 were
maintained in vitro and synchronized according to standard
procedures (Blackman, 1994; Yeoh et al., 2007) in RPMI 1640
medium containing the serum substituteAlbumax (Invitrogen).
For introduction of transfection constructs, mature schizonts
were enriched from highly synchronous cultures using Percoll
(GE Healthcare) as described previously (Harris et al., 2005),
and transfected by electroporation with 10 mg of circular
plasmid DNA using the Amaxa 4D electroporator (Lonza) and
the P3 Primary cell 4D Nucleofector X Kit L (Lonza) and
program FP158, exactly as recently described for P. knowlesi
(Moon et al., 2013). Selection for parasites harbouring the
plasmid was performed by culture in medium containing 2.5
nM WR99210. Selection for parasites in which integration of
transfected DNA into the genome had taken place was pro-
moted by cycles of culture in the absence and presence of
WR99210, as described previously (Harris et al., 2005). When
integration was detected by diagnostic PCR, integrant clones
were obtained by limiting dilution and maintained in medium
containing WR99210. Parasite growth rates were assessed by
microscopic examination of Giemsa-stained thin films at 2-day
intervals, and expressed as percentage parasitaemia (per-
centage of parasitized erythrocytes in the population)
Production of P. falciparum transfection vector
pHH1SERA5chimWT
A synthetic, recodonized SERA5 gene (SERA5synth), codon-
optimized for expression in Escherichia coli and based on
the predicted P. falciparum 3D7 sequence (PlasmoDB ID
PF3D7_0207600) was synthesized by GeneArt AG (Regens-
burg, Germany) and provided with terminal 5’ SalI and 3’ XhoI
sites. A 940 bp targeting sequence including the second
and third intron of the SERA5 gene (PlasmoDB ID
PF3D7_0207600) was amplified by PCR from P. falciparum
3D7 genomic DNA using the oligonucleotide pair
+S5endogHpaI and -S5endogClaI (see Supporting informa-
tion Table S1 for all primer sequences used in this work). A
3’-segment of the recodonized SERA5synth gene was amplified
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by PCR using the oligonucleotide pair +S5Seq1021 and
-S5stopXhoI. The PCR amplicons, of 957 bp and 2007 bp
respectively, were ligated into pCR-Blunt using the Zero Blunt
PCR Cloning Kit (Invitrogen). Clones with a suitable insert
orientation were selected and then the endogenous SERA5
targeting sequence was ligated in frame to the 5’ end of the 3’
segment of the SERA5synth gene, using restriction sites KpnI
(derived from the pCR-Blunt multiple cloning site) and ClaI.
The entire chimeric sequence was then excised with HpaI and
XhoI and ligated into pHA3.HH1 (Yeoh et al., 2007) to produce
pHH1SERA5chimWT. This final construct comprised 940 bp
of authentic SERA5 sequence (the targeting sequence), fused
in frame to 1800 bp of recodonized synthetic SERA5synth
sequence encoding the remaining 3’ region of the SERA5
ORF, followed by a stop codon, an XhoI site, then a 3HA
epitope tag sequence, and another stop codon, all directly
upstream of the 3’ UTR from the P. berghei dihydrofolate
reductase (dhfr) gene (Pbdt 3’ UTR).
Production of the PfDiCre cassette
PCR amplification was conducted using AccuPrime™ Pfx
SuperMix (Invitrogen, UK) and when required PCR products
were subcloned into the pScB subcloning vector (Aligent
Technologies, UK). A ‘mock’ promoter region was amplified
from E. coli genomic DNA using primers EWmock1 and
EWmock2. The resulting amplicon (corresponding to ~ 930 bp
of the E. coli pmba gene, GenBank/EMBL Accession No.
X54152) was subcloned into pScB. Restriction digestion of the
intermediate vector using PstI and HindIII released the mock
promoter fragment which was subsequently cloned into the
pBlueScript SK+ phagemid (GenBank/EMBL Accession No.
X52328) pre-digested with PstI and HindIII, to form pmockINT.
The FKBP-Cre59 gene was amplified using primers
EWCRE59For and EWCRE59Rev from plasmid TUB8FKBP-
Cre59-HX (Andenmatten et al., 2013), and subcloned into PstI
and EcoRI-digested pmockINT to create pCre59INT. The 3’
UTR of the P. falciparum calmodulin gene (PfCAM) was
amplified from P. falciparum genomic DNA using primers
EWCAM3For and EWCAM3Rev. The PCR fragment was sub-
cloned into pScB. To excise the 3’ CAM fragment, the inter-
mediate vector was digested with NotI and PstI and inserted
into pCre59INT to form the pCre59 vector. The FRB-Cre60
coding sequence was amplified by PCR using primers
EWCRE60For and EWCRE60Rev from plasmid
TUB8FRBCre60-HX (Andenmatten et al., 2013). The ampli-
con was subcloned into pScB, released using HindIII and KpnI
and ligated into the pCre59 vector to form pCre59/Cre60INT.
Finally, the hsp86 3’ UTR was amplified by PCR from P. falci-
parum genomic DNA using primers EWHSP863For and
EWHSP863Rev, cloned into pScB, released with ClaI and
KpnI and ligated into pCre59/Cre60INT to create the ‘mock’
pCre59/Cre60 DiCre vector called (DiCre24A). To obtain
expression of DiCre in P. falciparum, the mock promoter in this
vector was replaced with the P. falciparum hsp86 and BiP
promoters, arranged in a head-to-head orientation. To do this,
the hsp86 5’ flanking region was amplified from pA289-attP-
BSD (a kind gift of Andy Osborne, University College London,
UK) using primers hsp86 5’_F1 and hsp86 5’_R1. The result-
ing product was cloned into DiCre24A using EcoRI and HindIII
restriction sites, replacing the mock promoter region and
giving rise to plasmid pBS_DC_hsp86. The BiP 5’ UTR was
amplified from pHH4 using primers bip_F1 and bip_R1, and
cloned into pBS_DC_hsp86 using AfeI and EcoRI, giving rise
to the PfDiCre expression cassette vector pBS_DC_hsp86/
Bip5’.
Production of P. falciparum transfection vector
pHH1_SERA5del3DC
This construct was designed to integrate by single crossover
homologous recombination into the SERA5 locus in such a
manner that DiCre-mediated excision from the modified locus
would remove its introduced 3’ UTR (Pbdt 3’ UTR), as well as
removing the hdhfr selectable marker cassette from the modi-
fied locus. Cloning of other target gene sequences into the
transfection plasmid can be carried out using a restriction site
in the multiple cloning site (MCS) and the unique XhoI
site immediately downstream of the recodonized SERA5
sequence (with or without a stop codon depending on whether
the 3HA epitope tag is required) or the unique AvrII site.
PCR reactions were performed using pHH1SERA5chimWT
as template, and primers sgS5seq4F and 3HA_AvrII_LoxP or
AvrII_LoxP_PbDT3’_F and NotI_PbDT3’_R. Products from
these reactions were mixed in equal amounts and an over-
lapping PCR carried out using primers sgS5seq4F and
NotI_PbDT3’_R. The resulting amplicon was cloned into
pHH1SERA5chimWT using the XhoI and NotI restriction sites,
generating plasmid pHH1_sera5_LoxP1. This now contained
an AvrII and a loxP site between the 3HA tag and Pbdt 3’ UTR
sequences. To incorporate the loxP site and a MCS (compris-
ing SpeI, SnaBI, AflII and HpaI sites) upstream of the SERA5
targeting gene sequence in this plasmid, three sequential
rounds of PCR amplification were carried out using forward
primers (i) MCS_HpaI, (ii) U1_MCS and (iii) LoxP_MCS_XL
and reverse primer EndoS5_R1. The resulting amplicon was
blunt ended with T4 DNA polymerase then digested with
BstZ171 and cloned into pHH1_sera5_LoxP1 pre-digested
with HpaI and BstZ171, giving rise to plasmid
pHH1_PreDiCre_A. This was digested with EcoRI, blunted
with T4 DNA polymerase and re-ligated to remove the EcoRI
site, giving rise to 3A_DEcoRI. This was digested with HindIII,
blunted with T4 DNA polymerase and re-ligated to remove the
HindIII site, giving rise to pHH1_PreDC_A_DH/DE. The entire
DiCre cassette from plasmids DiCre24A or pBS_DC_hsp86/
Bip5’ was finally cloned into pHH1_PreDiCre_A and
pHH1_PreDC_A_DH/DE respectively, using the SpeI and AflII
restriction sites, to produce the final transfection constructs,
pHH1_DCmock and pHH1_SERA5del3DC.
Production of P. falciparum reporter transfection vector
pHH1_MSP1del3preDiCre
This construct was used to assay for inducible DiCre activity
in the 1G5DiCre P. falciparum subclone. Briefly, it is identical
to pHH1_PreDiCre_A described above except that the chi-
meric SERA5 sequence was replaced with ~ 990 bp of msp1
sequence fused in frame to ~ 1400 bp of recodonized msp1
sequence. The plasmid therefore contains two loxP sites
flanking the Pbdt 3’ UTR and hdhfr cassette. Full details of
production of this construct will be provided in a later paper
(S. Das and M. Blackman, in preparation).
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Indirect immunofluorescence (IFA) and Western blot
IFA and Western blot analysis using mAbs 24C6.1F1 and
X509 were performed as described previously, using SDS-
extracts of mature intact Percoll-enriched schizonts for the
Western blot analysis (Jean et al., 2003), and formaldehyde-
fixed thin films of cultures containing mature schizonts for the
IFA (Harris et al., 2005; Ruecker et al., 2012).
Southern blot
For Southern blot analysis, a 597 bp probe corresponding to
endogenous SERA5 coding sequence lying just upstream of
the targeting sequence in constructs pHH1SERA5chimWT,
pHH1_A_DC_mock and pHH1_3A_H + B_DH/E_SERA5
(which was identical in all cases) was produced by PCR
amplification from P. falciparum 3D7 genomic DNA with
primers SERA5_US_F and SERA5_US_R (Table S1). Radi-
olabelling of the probe and hybridization to HindIII/EcoNI-
digested genomic DNA from parasite clones of interest was
performed as described previously (Ruecker et al., 2012).
Quantification of the conversion of the signal corresponding
to the non-excised modified SERA5 locus to the excised form
was performed by phosphorimager analysis on a STORM
860 Molecular Imager (GE Healthcare) using ImageQuant
software.
3’ Rapid amplification of cDNA ends (3’ RACE)
Total RNA from the 3E9 P. falciparum clone (non-rapamycin-
treated) and the 1G5DiCre subclone was prepared using a
TRIzol Plus RNAisolation kit. First-strand cDNAsynthesis was
conducted using 3 mg of total RNA, oligo dT adapter primers
and SuperScript II reverse transcriptase, using a 3’ RACE kit
(Invitrogen) according to the manufacturer’s protocol. Subse-
quently, semi-nested PCR reactions were performed to spe-
cifically amplify cDNA derived from polyadenylated SERA5
mRNA, using SERA5synth-specific primers SERA5_3R1 and
SERA5_3R2 (Table S1) as first and second gene-specific
primers. For both PCR reactions AUAP from the 3’ RACE kit
was used as the reverse primer. PCR products were purified
(Qiagen MinElute kit) and cloned into the pGEM T-Easy vector
(Promega) for nucleotide sequencing.
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